To evaluate the application of interferon gamma release assay (IGRA),
| INTRODUCTION
On a global scale, tuberculosis remains a major infectious disease, presenting approximately nine million new cases and two to three million deaths annually. About one-eighth of these are extrapulmonary tuberculosis, 1 which includes an estimated 11.3%-34.5% of bone and joint tuberculosis patients. 2 Because bone and joint tuberculosis onset is often occult and progression is slow, it is difficult to diagnose. In addition, bacteria of articular effusion in lesion sites are less frequent, and specimens are not easy to obtain, which further reduces the positive rate of puncture fluid or joint surgical specimens. 3 These factors make the early diagnosis of bone and joint tuberculosis extremely challenging. However, the early diagnosis of bone and joint tuberculosis is essential as Mycobacterium tuberculosis can cause inflammation after the invasion of the joint and mass proliferation in the cells, leading to limited mobility and destruction of immune system functions. 4 However, early treatment can reduce the incidence of physical disability and injury. Early symptoms of bone and joint tuberculosis are not obvious, and signs and imaging features are atypical, making diagnosis difficult, so that diagnosis of the disease is often overlooked.
5,6
The gold standard for the diagnosis of human tuberculosis is the detection of Mycobacterium tuberculosis using microbiological methods.
However, traditional solid and liquid culture methods may take several weeks to produce a positive result, and the positive rate of joint tuberculosis detection is very low, 7 which often delays the treatment period or even leads to a misdiagnosis. In this case, rapid and sensitive indicators are needed to improve the level of diagnosis, especially in the difficult diagnoses, misdiagnoses, and completely missed diagnoses.
It is imperative to establish sensitive and specific laboratory testing technologies to assist in clinical diagnosis. This has been hailed as a breakthrough in the diagnosis of tuberculosis by the WHO.
Interferon gamma release assay (IGRA) guidelines were updated in 2010. 10 The IGRA is based on enzyme-linked immunospot (ELISPOT) assay formats. ELISPOT technology is an innovative immune enzyme technology which detects antibody secretion cells or cytokine cells at the single-cell level. T-SPOT. TB, developed by ELISPOT, stimulates peripheral mononuclear blood cells using Mycobacterium tuberculosisspecific antigens, detects antigen-specific T-lymphocyte response by secretion of cytokine interferon-γ with a high sensitivity and specificity, 11, 12 and, thus, determines the state of tuberculosis infection. It is the most successful application of Mycobacterium tuberculosis genomics and its cellular immune research in the field of tuberculosis in the last 10 years.
13
Tumor necrosis factor alpha (TNF-α) has immunomodulatory effects on leukocytes, vascular endothelial cells, and the cytokines of connective tissue. It can stimulate cells to produce prostaglandins and proteases, and it can also enhance vascular permeability with a proinflammatory effect. 14 Transforming growth factor beta(TGF-β) is primarily involved in inflammatory reaction and damage repair affecting cell proliferation and differentiation. It plays an immunomodulatory role in tuberculosis tissue and simultaneously inhibits T-cell response by the inactivation of macrophages. 15 The expression of TNF-α and TGF-β plays an important role in the process of protective immune response and allergic reaction, which is closely related to the injury and repair of bone and joint tissue. 16 The purpose of this study is to evaluate the application of Xpert MTB/RIF and IGRA tests in the diagnosis of bone and joint tuberculosis, and to explore the diagnostic value of TNF-α and TGF-β levels.
| METHODS AND MATERIALS

| Subjects
Eighty-six patients who were diagnosed with bone and joint tuber- with a mean age of 36±14 years; 49 patients were male, and 37 were females. There were 30 healthy people in the control group, 13 males and 17 females aged 29-59 years with a mean age of 37±9 years.
Physical indicators were normal, excluding AIDS, hypertension, cardiac dysfunction, and other diseases, and no patient had a history of living with a family member who was tuberculosis patient. There were no statistically significant differences in age and gender (P>.05). The study protocol was approved by the Institute and National Scientific and Ethical Committees, and consent to participate in the study was obtained from each individual.
| Samples and reagents
A 2 mL sample of lesions joint pus was taken from each patient with bone and joint tuberculosis, and a 2 mL sample of randomized joint fluid was taken from each of the healthy people. These samples were centrifuged at 1509 g for 15 minutes and then reserved for Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) assays at a later time.
Treatment of joint fluid samples was performed with reference to the sputum method. 9 A fasting peripheral venous blood sample of 2 mL was collected from all patients, and these were then stored at −20°C
for reserving, after separating plasma with centrifuging for 5 minutes at 1509 g, in order to perform IGRA (Oxford Immunotech, Abingdon, UK) and to measure TNF-α and TGF-β levels. The specific operational processes of IGRA test can be queried. 17 TNF-α and TGF-β levels were detected by enzyme-linked immunosorbent assay (ELISA), which was done according to the manufacturer's (R&D Systems, Minneapolis, MN, USA) instructions. The standard curve was plotted against the standard value of A, and then plasma TNF-α and TGF-β levels were calculated by the ELISA method, using matched antibody pairs and their corresponding standards.
| Statistical analysis
Statistical analysis was calculated using IBM SPSS ver.19.0 (IBM, Armonk, NY, USA) software. Continuous variables were compared using the Mann-Whitney test. Categorical variables were compared using Pearson chi-square. Spearman's correlation coefficient was used to assess the association between the levels of TNF-α and TGF-β in the bone and joint tuberculosis patients. Receiver operating characteristic (ROC) curves were constructed to assess the sensitivity and specificity of the obtained TNF-α and TGF-β measurements to compare their ability to diagnose bone and joint tuberculosis. All reported P values in the study were two-tailed, and there was a statistically significant difference when P<.05.
| RESULTS
The Xpert MTB/RIF and IGRA test results are shown in Table 1 . The sensitivity and specificity of the two test methods are given in Table 2 .
Eighty-six bone and joint tuberculosis patients were examined by the pus Xpert MTB/RIF and plasma IGRA detection methods, respectively. The sensitivity of the IGRA in the diagnosis of bone and joint tuberculosis was 81.4%, and the sensitivity of the Xpert MTB/RIF was 70.9%. Results were considered positive when two methods were positive or one of them was positive (79 cases); results were negative when the two detection methods were negative (7 cases). The sensitivity of the combined detection of the two methods was 91.9%, and the combined specificity was 96.7%. With 100% and 96.7% specificity, the positive likelihood ratio (PLR) and positive predictive value (PPV) for the two methods were excellent ( There was a positive correlation between the expressions of TNF-α and TGF-β in the hyperplastic lesion group (Figure 1) , and the expression of TNF-α was significantly higher in the hyperplastic lesion group than in the caseous necrosis lesion group (P<.001). There was a negative correlation between the expression of TNF-α and TGF-β in the caseous necrosis lesion group (Figure 2) , and the expression of TGF-β was significantly higher in the caseous necrosis lesion group than in the hyperplastic lesion group (P<.001). Compared with the control group, the levels of TNF-α and TGF-β were significantly higher in the cases of hyperplastic lesion and caseous necrosis lesions (Table 3) , and the dif- 
| DISCUSSION
Over time, more and more studies have been done on the mechanisms of pulmonary tuberculosis damage to the body, but less research exists on bone and joint tuberculosis. As a common extrapulmonary tuberculosis, bone and joint tuberculosis can cause limb deformity, limited mobility, and even paraplegia if improperly treated, 18 and it is divided into hyperplastic and caseous necrotic tuberculosis, according to the main pathological changes of tuberculosis. 19 At present, the early diagnosis and differential diagnosis of atypical cases are also more challenging as no single test can diagnose all bone and joint tuberculosis patients. The current study shows that the Xpert MTB/RIF has demonstrated superior performance in sputum samples of tuberculosis. 9, 20 The IGRA also showed a surprising performance in tuberculosis patients. 21 In this study, 86 patients diagnosed with bone and joint tuberculosis by histopathology and Mycobacterium tuberculosis by microbiological methods, were examined by the pus Xpert MTB/ RIF and the plasma IGRA tests, respectively. The results showed that the sensitivity of the Xpert MTB/RIF test in the diagnosis of bone and joint tuberculosis was 70.9%, and specificity was 100%, which is consistent with previous reports 9, 20 (the sensitivity was 67%-98%, the specificity was 98%). Moure et al. 22 proposed that the sensitivity of the Xpert MTB/RIF test to sterile body fluid specimens was lower than in sputum samples, and they showed that it was 76.5% in abscess inhalers. The positive detection rate of the IGRA in bone and joint tuberculosis patients was higher than with the Xpert MTB/RIF, sensi- As a multifunctional cytokine, TNF-α can increase the phagocytosis of macrophages, chemotaxis, and adhesion of many immune cells; thus, when it is located in the site of infection of tuberculosis, it plays a very important role in preventing the spread of infection. 26 Recent studies have shown that TNF-α participates in osteoclast differentiation and biological activity regulation in a variety of ways. 27 Additionally, TNF-α can promote the macrophage apoptosis of Mycobacterium tuberculosis while inhibiting the replication of Mycobacterium tuberculosis. It can be said TNF-α has an important role in stability in the maintenance of tuberculosis in the human body. 28 The results showed that the levels of TNF-α in hyperplasia and caseous necrosis lesions were significantly higher than those in normal controls (P<.001), suggesting that TNF-α is involved in anti-infective immunoregulation in bone and joint tu- Excessive TGF-β will further chemotaxis monocytes and neutrophils gathering in the site of the tuberculosis infection, increasing collagenase and elastase production, and leading to other complications such as extensive tuberculosis tissue damage, vacuolation, and fibrosis.
32
Some studies suggest that TGF-β and TNF-α have a synergistic effect by formatting tissue damages with a characteristic of tuberculosis. 33 This study showed that the high expressions of TGF-β and TNF-α were associated with each other in the hyperplastic lesion group, and the correlation analysis showed that the expression levels of TGF-β and TNF-α were positively correlated. However, the high expressions of TGF-β and TNF-α were not associated with each other in the caseous necrosis lesion group; the correlation analysis showed that the expression levels of TGF-β and TNF-α were negatively correlated. The reason may be that, in monocytes and macrophages, high levels of TGF-β not only down-regulate the production and activity of TNF-α, but also reduce the generation of reactive oxygen intermediates, leading to inactivation of monocytes macrophages 34 and to further deterioration of the patient's condition. Therefore, high expression of TGF-β and low expression of TNF-α may be factors leading to necrosis and ulceration of granuloma, indicating that TGF-β is involved in tissue damage that leads to the disease's progression. The results of ROC analyses indicated that the levels of TGF-β and TNF-α are specific and sensitive for the diagnosis of bone and joint tuberculosis in patients. They might be suitable diagnostic markers of bone and joint tuberculosis with a distinct difference in levels between the hyperplasia lesion and caseous necrosis groups and the controls.
Thus, it can be seen that the combination of Xpert and IGRA tests can better improve the detection rate of bone and joint tuberculosis. Our findings also show that TGF-β and TNF-α may be involved in the pathogenesis of bone and joint tuberculosis. Recent studies have
shown that TNF-α was associated with a predisposition to bone and joint tuberculosis, which could aid clinical detection, prevention, and prognosis of bone and joint tuberculosis. 35 This is consistent with our research. However, it must be noted that TGF-β and TNF-α levels will require further research as to their potential to be of value in the diagnosis of bone and joint tuberculosis. Studies have shown that TNF-α is also increased in ankylosing spondylitis, rheumatoid arthritis, and other diseases. [36] [37] [38] Therefore, it has been proven that TNF-α participates in the pathogenesis of various diseases as a multifunctional cytokine. However, although it does not belong to the specific diagnostic indicator of bone and joint tuberculosis at this time, it may nevertheless be helpful in the diagnosis of bone and joint tuberculosis in the future. In particular, expression of TGF-β and TNF-α levels were negatively correlated in caseous necrotic lesions in our study, which may be differentiated from other diseases. However, these findings are still subject to further experimental observations. Despite these factors, in the case of a difficult diagnosis of bone and joint tuberculosis, the clinician who is trying to achieve the highest possible probability of the correct diagnosis must always attempt to employ every possible diagnostic tool that is available. Therefore, detection that combines the Xpert and IGRA tests with analysis of TNF-α and TGF-β levels offers a distinct possibility to improve the accuracy of the diagnosis.
Our study has some limitations. First, the study was conducted in a high burden setting of tuberculosis, which may limit the universality of the findings, so the data may not be fully representative of the situation in other countries. Second, the sample number of this study is limited, and the current literature on bone and joint tuberculosis reports is scant. Also, the serum indicators used in this study for diagnosis of bone and joint tuberculosis are still insufficient, several diagnostic strategies and tools need to be examined and confirmed in future studies.
| CONCLUSION
In summary, no single test exists that is sufficient to diagnose all bone and joint tuberculosis patients. However, our results show that the Xpert and IGRA tests, along with an analysis of TNF-α and TGF-β levels, can be regarded as rapid indicators of bone and joint tuberculosis F I G U R E 3 Evaluation of serum TGf-β and TNF-α for the diagnosis of bone and joint tuberculosis by roc curve analysis which have the potential to greatly improve diagnosis. When early diagnosis is difficult, the combination of the above-referenced tests and levels can provide clinicians with information more efficient in the diagnosis of bone and joint tuberculosis, which would enable patients to receive the most effective treatment in the shortest amount of time.
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